These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 26935702)

  • 1. The Potential Use of Piglets as Human Pediatric Surrogate for Preclinical Pharmacokinetic and Pharmacodynamic Drug Testing.
    Gasthuys E; Vandecasteele T; De Bruyne P; Walle JV; De Backer P; Cornillie P; Devreese M; Croubels S
    Curr Pharm Des; 2016; 22(26):4069-85. PubMed ID: 26935702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of juvenile pigs to serve as human pediatric surrogates for preclinical formulation pharmacokinetic testing.
    Roth WJ; Kissinger CB; McCain RR; Cooper BR; Marchant-Forde JN; Vreeman RC; Hannou S; Knipp GT
    AAPS J; 2013 Jul; 15(3):763-74. PubMed ID: 23595360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preclinical pharmacokinetic/pharmacodynamic modeling and simulation in the pharmaceutical industry: an IQ consortium survey examining the current landscape.
    Schuck E; Bohnert T; Chakravarty A; Damian-Iordache V; Gibson C; Hsu CP; Heimbach T; Krishnatry AS; Liederer BM; Lin J; Maurer T; Mettetal JT; Mudra DR; Nijsen MJ; Raybon J; Schroeder P; Schuck V; Suryawanshi S; Su Y; Trapa P; Tsai A; Vakilynejad M; Wang S; Wong H
    AAPS J; 2015 Mar; 17(2):462-73. PubMed ID: 25630504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic/pharmacodynamic studies in drug product development.
    Meibohm B; Derendorf H
    J Pharm Sci; 2002 Jan; 91(1):18-31. PubMed ID: 11782894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pig as a preclinical model for predicting oral bioavailability and in vivo performance of pharmaceutical oral dosage forms: a PEARRL review.
    Henze LJ; Koehl NJ; O'Shea JP; Kostewicz ES; Holm R; Griffin BT
    J Pharm Pharmacol; 2019 Apr; 71(4):581-602. PubMed ID: 29635685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pediatric pharmacology: current efforts and future goals to improve clinical practice.
    Krekels EH; Tibboel D; Knibbe CA
    Expert Opin Drug Metab Toxicol; 2015; 11(11):1679-82. PubMed ID: 26166262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repetitive urine and blood sampling in neonatal and weaned piglets for pharmacokinetic and pharmacodynamic modelling in drug discovery: a pilot study.
    Gasthuys E; Schauvliege S; van Bergen T; Millecam J; Cerasoli I; Martens A; Gasthuys F; Vandecasteele T; Cornillie P; Van den Broeck W; Boyen F; Croubels S; Devreese M
    Lab Anim; 2017 Oct; 51(5):498-508. PubMed ID: 28178895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population approaches in paediatrics.
    Chatelut E
    Fundam Clin Pharmacol; 2008 Dec; 22(6):575-8. PubMed ID: 19049657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of modeling and simulation in pediatric investigation plans.
    Manolis E; Osman TE; Herold R; Koenig F; Tomasi P; Vamvakas S; Saint Raymond A
    Paediatr Anaesth; 2011 Mar; 21(3):214-21. PubMed ID: 21244569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Children in clinical trials: towards evidence-based pediatric pharmacotherapy using pharmacokinetic-pharmacodynamic modeling.
    Brussee JM; Calvier EA; Krekels EH; Välitalo PA; Tibboel D; Allegaert K; Knibbe CA
    Expert Rev Clin Pharmacol; 2016 Sep; 9(9):1235-44. PubMed ID: 27269200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical research in neonates and infants: Challenges and perspectives.
    Coppini R; Simons SHP; Mugelli A; Allegaert K
    Pharmacol Res; 2016 Jun; 108():80-87. PubMed ID: 27142783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analyzing the Potential Root Causes of Variability of Pharmacokinetics in Preclinical Species.
    Daublain P; Feng KI; Altman MD; Martin I; Mukherjee S; Nofsinger R; Northrup AB; Tschirret-Guth R; Cartwright M; McGregor C
    Mol Pharm; 2017 May; 14(5):1634-1645. PubMed ID: 28329443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug Development for Pediatric Populations: Regulatory Aspects.
    Zisowsky J; Krause A; Dingemanse J
    Pharmaceutics; 2010 Nov; 2(4):364-388. PubMed ID: 27721363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacokinetic and pharmacodynamic modelling in paediatric drug development with a focus on physiology-based pharmacokinetic simulations].
    Läer S
    Z Evid Fortbild Qual Gesundhwes; 2019 May; 141-142():66-73. PubMed ID: 30935788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developmental Pharmacodynamics and Modeling in Pediatric Drug Development.
    Conklin LS; Hoffman EP; van den Anker J
    J Clin Pharmacol; 2019 Sep; 59 Suppl 1(Suppl 1):S87-S94. PubMed ID: 31502687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical studies of 5-fluoro-2'-deoxycytidine and tetrahydrouridine in pediatric brain tumors.
    Morfouace M; Nimmervoll B; Boulos N; Patel YT; Shelat A; Freeman BB; Robinson GW; Wright K; Gajjar A; Stewart CF; Gilbertson RJ; Roussel MF
    J Neurooncol; 2016 Jan; 126(2):225-34. PubMed ID: 26518542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Animal Pharmacokinetic/Pharmacodynamic Studies (APPS) Reporting Guidelines.
    Singh J; Elbarbry F; Lan K; Grabowski T
    Eur J Drug Metab Pharmacokinet; 2018 Oct; 43(5):483-494. PubMed ID: 30117069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A physiologically based pharmacokinetic and pharmacodynamic (PBPK/PD) model of the histone deacetylase (HDAC) inhibitor vorinostat for pediatric and adult patients and its application for dose specification.
    Moj D; Britz H; Burhenne J; Stewart CF; Egerer G; Haefeli WE; Lehr T
    Cancer Chemother Pharmacol; 2017 Nov; 80(5):1013-1026. PubMed ID: 28988277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diuretics in pediatrics : current knowledge and future prospects.
    van der Vorst MM; Kist JE; van der Heijden AJ; Burggraaf J
    Paediatr Drugs; 2006; 8(4):245-64. PubMed ID: 16898855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meta-analysis of hepatic cytochrome P450 ontogeny to underwrite the prediction of pediatric pharmacokinetics using physiologically based pharmacokinetic modeling.
    Upreti VV; Wahlstrom JL
    J Clin Pharmacol; 2016 Mar; 56(3):266-83. PubMed ID: 26139104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.